PAR 1.69% 29.0¢ paradigm biopharmaceuticals limited..

Repurposed drugs - a surging business model?, page-2

  1. b20
    164 Posts.
    lightbulb Created with Sketch. 32
    Good idea and something I have also been pondering.
    I was aware of IXC and now good to know about RAC.
    More research to be done.

    Another thought would be to look at any companies who have used the repurposed model and how they have fared ie timelines etc.
    I unfortunately do not know of any.
 
watchlist Created with Sketch. Add PAR (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.